Viewing Study NCT03915626



Ignite Creation Date: 2024-05-06 @ 1:02 PM
Last Modification Date: 2024-10-26 @ 1:08 PM
Study NCT ID: NCT03915626
Status: COMPLETED
Last Update Posted: 2022-04-04
First Post: 2019-03-05

Brief Title: Effect of Heat on Rivastigmine TDS Products
Sponsor: University of Maryland Baltimore
Organization: University of Maryland Baltimore

Study Overview

Official Title: Determination of Serum Rivastigmine Levels After Using Rivastigmine Transdermal Delivery Systems With and Without Standardized Heat Application in Healthy Human Volunteers
Status: COMPLETED
Status Verified Date: 2022-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: This research study is designed to measure the amount of medicine in blood over time after the patch is placed on the skin with and without external heat application
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: True
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: None